🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-center, single-arm, interventional phase I/II trial to eva...
Status
Withdrawn
Location
Masonic Cancer Center - University of Minnesota
Start Date
2024-09
Trial ID
NCT05114837
Treatments Being Tested
The goal of this study is to evaluate the efficacy of HMPL-760 in combinati...
Status
Active Not Recruiting
Location
Fujian Medical University Union Hospital
Start Date
2024-11-05
Trial ID
NCT06601504
This phase II trial studies how well polatuzumab vedotin and combination ch...
Status
Active Not Recruiting
Location
Karmanos Cancer Institute
Start Date
2020-08-21
Trial ID
NCT04479267
This is a phase 1b/II, open label, multicenter study of IBI310 (Anti-CTLA4 ...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2021-07-23
Trial ID
NCT04945421
Treatments Being Tested
This multicenter, open-label, dose-escalation study will evaluate the safet...
Status
Completed
Location
The University of Alabama at Birmingham
Start Date
2013-11-29
Trial ID
NCT01992653
Treatments Being Tested
This study will evaluate the immunogenicity, safety, and tolerability of VA...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0018)
Start Date
2017-10-17
Trial ID
NCT03239873
Treatments Being Tested
Regorafenib is an oral medication that can interfere with cancer cell growt...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2014-03
Trial ID
NCT02098538
Treatments Being Tested
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
This is a prospective, single-arm, phase II clinical trial. The purpose of ...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-07-09
Trial ID
NCT06802835
Treatments Being Tested
This phase III trial studies combination chemotherapy with or without lesta...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2008-01-15
Trial ID
NCT00557193
Treatments Being Tested